D.E. Shaw & Co
MBIO icon

D.E. Shaw & Co’s Mustang Bio MBIO Stock Holding History

D.E. Shaw & Co’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-584
Closed -$443K – 5584
2022
Q1 		$443K Buy
584
+175
+43% +$144K ﹤0.01% 4446
2021
Q4 		$509K Buy
409
+256
+167% +$413K ﹤0.01% 4390
2021
Q3 		$308K Buy
153
+65
+74% +$140K ﹤0.01% 4337
2021
Q2 		$220K Buy
+88
New +$216K ﹤0.01% 4413

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

D.E. Shaw & Co's MBIO Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 584 shares — an estimated $443K sold.

D.E. Shaw & Co first reported a position in MBIO in Q2 2021 and held it in 4 quarters. The position peaked at $509K in Q4 2021. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 584 Mustang Bio shares in Q2 2022, an estimated $443K.
  • D.E. Shaw & Co first reported a position in Mustang Bio in Q2 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's Mustang Bio position peaked at $509K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.